NCT00501618View on ClinicalTrials.gov

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

PHASE4CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

July 31, 2009

Conditions

SchizophreniaSchizoaffective Disorder

Interventions

DRUG

Fazaclo

single-arm

Trial Locations (2)

10027

Manhattan Psychiatric Center, 125th Street, Out Patient Clinic, New York

10035

Manhattan Psychiatric Center, Inpatient Unit, New York

Sponsors

Collaborators (1)

Azur Pharma, Inc

All Listed Sponsors

collaborator

Azur Pharma, Inc

INDUSTRY

lead

Manhattan Psychiatric Center

OTHER

NCT00501618 - Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder | Biotech Hunter | Biotech Hunter